Spontaneous ascitic fluid infection and bacteremia due to Yersinia pseudotuberculosis in a liver transplant patient.

Abstract

We report herein a case of bacteremic ascitic fluid infection in a liver transplant patient caused by a strain of Yersinia pseudotuberculosis serogroup I that lost the yersiniabactin core. The patient's outcome was favorable after a combined therapy with a third-generation cephalosporin and gentamicin.

• Authors: A Renvoisé, N Lemaitre, G Saintenoy, H Benosman, C Geffrier, L Epelboin, V Jarlier, T Poynard, D Thabut
• Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (Int J Infect Dis) Vol. 34 Pg. 122-5 (May 2015) ISSN: 1878-3511 [Electronic] Canada
• PMID: 25835101 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Chemical References

• Anti-Bacterial Agents
• Cephalosporins
• Gentamicins

Topics

• Anti-Bacterial Agents (therapeutic use)
• Ascitic Fluid (microbiology)
• Bacteremia (diagnosis, drug therapy, etiology)
• Cephalosporins (therapeutic use)
• Drug Therapy, Combination
• Gentamicins (therapeutic use)
• Humans
• Liver Transplantation
• Male
• Middle Aged
• Treatment Outcome
• Yersinia pseudotuberculosis (isolation & purification)
• Yersinia pseudotuberculosis Infections (diagnosis, drug therapy)